Heart failure in diabetes: effects of anti-hyperglycemic drug therapy
Studies on the cardiovascular safety of new anti-diabetic drugs have drawn attention to the problem of heart failure (HF) in patients with type 2 diabetes mellitus (T2DM). This has included one controversial study about hospitalization associated with HF in patients treated with dipeptidyl-peptidase...
Main Authors: | Gagik R. Galstyan, Mikhail Y. Gilyarov |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2016-07-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/7832/5866 |
Similar Items
-
Heart failure in diabetes: From an increased risk to a treatment target
by: Eberhard Standl
Published: (2018-12-01) -
Heart failure hospitalization with DPP-4 inhibitors: A systematic review and meta-analysis of randomized controlled trials
by: Awadhesh Kumar Singh, et al.
Published: (2019-01-01) -
Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
by: Ghadeer K. Dawwas, et al.
Published: (2018-07-01) -
Expert committee on introduction of incretin-based therapy in Russia: advance and failure
by: Editorial team Diabetes Mellitus
Published: (2012-09-01) -
Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus
by: Hyun Min Kim, et al.
Published: (2015-03-01)